Ibafloxacin

Ibafloxacin
Clinical data
Trade names	Ibaflin
AHFS/Drugs.com	International Drug Names
ATCvet code	QJ01MA96 (WHO) ;
Legal status
Legal status	CA: ℞-only; EU: Rx-only;
Identifiers
	IUPAC name 6,7-dihydro-5,8-dimethyl-9-fluoro-1-oxo-1H,5H-benzo[ij]quinolizine-2-carboxylic acid;
CAS Number	91618-36-9 ;
PubChem CID	71186;
ChemSpider	64324 ;
UNII	53VPK9R0T5;
KEGG	D04485 ;
CompTox Dashboard (EPA)	DTXSID8057853 ;
Chemical and physical data
Formula	C15H14FNO3
Molar mass	275.279 g·mol−1
3D model (JSmol)	Interactive image;
	SMILES Fc2cc1C(=O)/C(C(=O)O)=C\N3c1c(c2C)CCC3C;
	InChI InChI=1S/C15H14FNO3/c1-7-3-4-9-8(2)12(16)5-10-13(9)17(7)6-11(14(10)18)15(19)20/h5-7H,3-4H2,1-2H3,(H,19,20) ; Key:DXKRGNXUIRKXNR-UHFFFAOYSA-N ;
	(what is this?) (verify)

The printable version is no longer supported and may have rendering errors. Please update your browser bookmarks and please use the default browser print function instead.

Ibafloxacin (INN) is a fluoroquinolone antibiotic^[1] drug formally approved for use in the European Union for veterinary medicine.^[2]

References

^ Horspool LJ, van Laar P, van den Bos R, Mawhinney I (June 2004). "Treatment of canine pyoderma with ibafloxacin and marbofloxacin--fluoroquinolones with different pharmacokinetic profiles". Journal of Veterinary Pharmacology and Therapeutics. 27 (3): 147–53. doi:10.1111/j.1365-2885.2004.00561.x. PMID 15189300.
^ "EUROPEAN PUBLIC ASSESSMENT REPORT (EPAR) IBAFLIN" (PDF). European Medicines Agency. 1 September 2007.

This systemic antibiotic-related article is a stub. You can help Wikipedia by expanding it.

[1] Horspool LJ, van Laar P, van den Bos R, Mawhinney I (June 2004). "Treatment of canine pyoderma with ibafloxacin and marbofloxacin--fluoroquinolones with different pharmacokinetic profiles". Journal of Veterinary Pharmacology and Therapeutics. 27 (3): 147–53. doi:10.1111/j.1365-2885.2004.00561.x. PMID 15189300.

[2] "EUROPEAN PUBLIC ASSESSMENT REPORT (EPAR) IBAFLIN" (PDF). European Medicines Agency. 1 September 2007.

[1]